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Overview
Nurses are on the front lines of health care delivery, and many of them routinely administer 
immunizations. The authors describe the Centers for Disease Control and Prevention’s (CDC) 
vaccine safety monitoring systems, explaining how nurses can access inquiry channels and other 
immunization information resources. Examples of recent vaccine safety inquiries are also 
provided.
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Vaccines are one of the greatest public health achievements in history. Immunization has 
dramatically reduced the burden of vaccine-preventable diseases—improvements that have 
continued into the 21st century. (Centers for Disease Control and Prevention, 2011) A recent 
analysis of the 20 years since the U.S. Vaccine for Children program was created to pay for 
vaccines of children whose families could not afford them shows an estimated cost savings 
in preventing illnesses, hospitalizations, and premature deaths at $1.38 trillion. (Whitney 
CG, et al 2014)
Yet even as rates of illness and death from many vaccine-preventable diseases have 
decreased substantially—and even though the U.S. government maintains a comprehensive 
safety system governing vaccine development, licensure, and marketing (Salmon, Pavia, & 
Gellin, 2011)—concerns over vaccine safety persist, and such concerns are often 
unsupported by scientific evidence. (Larson, Cooper, Eskola, Katz, & Ratzan, 2011) For 
example, in spite of the Institute of Medicine’s exhaustive review of the scientific evidence 
and conclusion that the measles, mumps, and rubella (MMR) vaccine does not cause autism 
(Institute of Medicine 2012), this belief still persists among some people.
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What scientists have come to call “vaccine hesitancy” is resulting in a growing number of 
parents and others refusing or delaying recommended vaccinations for their children and for 
themselves. (Siddiqui, Salmon, & Omer, 2013) (The CDC’s recommended vaccine 
schedules for infants and children, teens, and adults are available online at www.cdc.gov/
vaccines/schedules.) Undervaccination has been implicated in local and regional outbreaks 
of vaccine-preventable diseases, such as measles. (Gastañaduy, et al., 2014; European 
Centre for Disease Prevention and Control, 2013) For example, between January 4 and April 
2 of 2015, 166 measles cases were reported in the United States, and over 80% of those were 
in people who were unvaccinated or had unknown vaccination status; the main reason for 
being unvaccinated was philosophical or religious beliefs. (Clemmons, et al., 2015)
Nurses often are the ones administering vaccines and therefore play a central role in 
teaching parents and patients about the lifesaving function of vaccines and about vaccine 
safety. According to a 2005 study, parents’ main source of information about vaccines is 
health care professionals, (Salmon et al, 2005) and so it is critical that nurses understand and 
communicate with parents the importance of vaccines. Nurses might also treat patients when 
vaccine adverse events require medical attention. The CDC has many resources available to 
nurses and other health care professionals on vaccine safety, including an established 
inquiry-and-response program. (Miller, et al. 2011)
In this article we describe the CDC’s vaccine-safety monitoring systems, explain how nurses 
and others can access the CDC’s inquiry channels and other resources, and give examples of 
recent inquiries and their resolution.
THE CDC’S VACCINE SAFETY MONITORING SYSTEMS
The CDC’s Immunization Safety Office (CDC-ISO) uses several systems to monitor vaccine 
safety and communicate this information to health care professionals and others.
The Vaccine Adverse Event Reporting System (VAERS) is the national frontline 
spontaneous reporting surveillance system and provides early warning for identifying 
potential vaccine safety concerns. (Iskander, Miller, & Chen, 2004) As a spontaneous 
surveillance system, however, it is not designed to assess whether a vaccine caused an 
adverse event. (Varricchio, et al., 2004) An example of a signal for an adverse event from 
VAERS was intussusception after RotaShield®, the first licensed rotavirus vaccine. 
RotaShield® was withdrawn from use in 1999 after a greater than expected number of 
reports of intussusception were detected in VAERS and an increased risk was confirmed in 
other studies. (Centers for Disease Control and Prevention, 1999)
The Vaccine Safety Datalink (VSD) uses electronic health record data from nine integrated 
health care organizations to conduct surveillance and epidemiologic studies. VSD data can 
be used to detect safety problems and assess and quantify risk for adverse events. (Baggs, et 
al., 2011) A VSD study was able to quantify the risk of anaphylaxis following vaccination in 
general in children and adolescents at one to two cases per million doses of vaccine 
administered. (Bohlke, et al, 2003)
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The Clinical Immunization Safety Assessment (CISA) Project, a network of vaccine 
safety experts at research medical centers, conducts clinical research, reviews complex 
vaccine safety cases and issues, and provides guidance to health care professionals on 
patients. (Williams, et al., 2013) Clinicians with a question about vaccine safety for a patient 
residing in the United States that isn’t answered by Advisory Committee on Immunization 
Practices (ACIP) guidelines can contact CISA via email at CISAeval@cdc.gov. The ACIP 
guidelines are recommendations for use of vaccinations in the United States and are 
available at http://www.cdc.gov/vaccines/hcp/acip-recs/index.html.
In addition to using data from VAERS and VSD and leveraging CISA to respond to 
inquiries, CDC-ISO relies on findings from clinical trials, ACIP recommendations and 
guidelines, Institute of Medicine reports, published studies, and input from CDC subject 
matter experts.
HOW TO GET CDC ASSISTANCE ON VACCINE SAFETY
Nurses can contact the CDC for vaccine safety inquiries through various channels (see Table 
1).
CDC-INFO, the CDC’s National Contact Center is staffed by both nonmedical and 
medical personnel who answer general and technical questions. Each day they field, on 
average, 1,000 calls, 250 e-mails, and six letters. They refer challenging questions and those 
requesting specific data to CDC scientific experts. Nurses with questions about vaccines can 
call 1-800-CDC-INFO or send a request online at http://wwwn.cdc.gov/dcs/
RequestForm.aspx.
NIPINFO (National Immunization Program Information)
The CDC’s immunization and vaccine-preventable-disease email inquiry system, NIPINFO, 
is staffed by physicians, nurses, and health educators from the CDC’s National Center for 
Immunization and Respiratory Diseases to answer immunization-related questions. Complex 
vaccine safety inquires that cannot be adequately addressed by NIPINFO are referred to 
CDC-ISO. Nurses can email questions to NIPINFO directly at NIPINFO@cdc.gov.
The CDC Emergency Operations Center (EOC), the command center for monitoring and 
coordinating emergency response activities, is staffed around the clock and has procedures 
in place for triaging emergency vaccine safety inquiries to CDC-ISO. The phone number is 
770-488-7100.
The VAERS program information line and email box
This resource provides answers on questions specifically related to VAERS reporting. 
Inquiries of a scientific or clinical nature are forwarded to CDC-ISO for a response. For 
VAERS reporting questions, nurses can call 1-800-822-7967 or send an email to 
Info@vaers.org
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The Clinical Immunization Safety Assessment (CISA) Project through the 
CISAeval@cdc.gov email address
CISA consults with and advises health care professionals about patients who experienced an 
adverse event after a vaccination and makes recommendations regarding future vaccinations 
for that patient. When it is determined that a submitted request does not require a CISA 
clinical consultation, it is referred to the CDC-ISO inquiry response program for a response.
EXAMPLES OF VACCINE SAFETY INQUIRIES AND CDC-ISO RESPONSES
Here are several examples of actual questions or concerns sent in to the CDC through 
various routes and synopses of the responses given.
Neurologic adverse event after influenza vaccine
In 2013 a member of the general public emailed CDC-INFO, which routed the question to 
NIPINFO, which sent it to CDC-ISO.
Question: “Can flu vaccine cause Guillain–Barré Syndrome, or GBS?”
Response: In 1976 an increased risk of GBS associated with swine influenza vaccine was 
reported—one to two additional cases per 100,000 people vaccinated. (Institute of Medicine, 
2004) The exact reason for this association remains unknown. Studies assessing the risk of 
GBS after seasonal influenza vaccine since 1976 have shown either no risk or a small 
increased risk on the order of one case per million doses administered. (Vellozzi, Iqbal, & 
Broder, 2014) Studies assessing an association of GBS with the 2009 H1N1 pandemic 
vaccine have shown a risk on the order of one to two GBS cases per million doses 
administered. (Salmon, et al., 2013)
A history of GBS within six weeks of receiving an influenza vaccine is a precaution for 
future doses of influenza vaccine in the patient. (Grohskopf, et al., 2014) A precaution is a 
condition that increases the risk for an adverse event in the vaccine recipient. In the case of a 
precaution, the health care provider must decide if the benefits of vaccination outweigh the 
risks. A contraindication indicates that the vaccine should not be given. (Kroger et al, 2011)
Vaccine administration errors or suspected errors involving seasonal influenza vaccine
Here are two examples.
The first was sent in 2013 by a U.S. military health care professional to the state health 
department and on to the CDC Emergency Operations Center and the CDC Influenza 
Division and finally to CDC-ISO.
Concern: Twenty personnel “were given inactivated influenza vaccine intranasally. This was 
not live influenza vaccine. Please provide guidance.” (Inactivated influenza vaccine is 
administered by intramuscular injection, and live attenuated influenza vaccine is 
administered by intranasal spray.)
Response: The 20 people who received inactivated influenza vaccine intranasally should be 
considered unvaccinated, advised of this, and be re-vaccinated with either inactivated 
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vaccine given intramuscularly or live attenuated influenza vaccine given intranasally. A 
search of the VAERS database for similar events revealed 72 people who had received 
inactivated influenza vaccine administered intranasally in error. None of these vaccine 
recipients reported adverse health events.
The second example was sent in 2012 by a community nurse practitioner (NP) to NIPINFO 
and on to CDC-ISO.
Concern: “I recently received a flu shot that was improperly given. It was given 1 to 2 
millimeters (not centimeters) below my acromion. At the time it felt like it went into a 
tendon or joint and it hurt. It was extremely painful that day and night and has since 
improved greatly. Are you familiar with this happening?”
Response: In its 2012 report, the Institute of Medicine concluded that the evidence 
convincingly supports a causal relationship between the injection of a vaccine and deltoid 
bursitis. (Institute of Medicine, 2012) A search of the VAERS database for similar reports 
for the 2011–2012 influenza season found 50 reports of the influenza vaccine being 
administered at an inappropriate site. Most reports stated that the injection was given “too 
high” in the arm, close to or at the shoulder area; a few stated the vaccine was given “too 
low” in the arm. Forty-nine of the 50 reported an adverse health event such as pain, 
decreased arm mobility, or bursitis.
As a result of this and similar inquiries, the CDC reached out to the American Nurses 
Association, the American College of Physicians, and the American Pharmacists 
Association to remind them of the importance of training and education in proper vaccine 
administration techniques (for additional information on this topic, see www.cdc.gov/flu/
professionals/vaccination). The outreach included a statement that “Giving the injection too 
low or too high can result in injection too close to the bone or joint.”
Sudden infant death syndrome (SIDS) following vaccination
In 2014, a health educator sent a question to CDC-INFO, which was sent on to NIPINFO 
and CDC-ISO.
Question: “Can vaccines cause SIDS?”
Response: The body of scientific evidence overwhelming supports the safety of childhood 
vaccination, and there is no credible evidence to suggest that vaccination increases the risk 
of SIDS or other unexpected infant death. (Institute of Medicine 2003; Vennemann, et al., 
2007)
In addition to the information and references provided on the CDC website at http://
www.cdc.gov/vaccinesafety/Concerns/sids.html, this response is supported by the results of 
a 2013 study by McCarthy and colleagues. (McCarthy, et al., 2013) which used VSD on 
more than 13 million vaccinated people in 10 U.S. health care organizations. Causes of 
death among those who died within 60 days of vaccination were compared with causes of 
death in the U.S. general population. The mortality rate among the vaccinated population 
was lower than that in the general U.S. population, and the causes of death were similar. 
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Among children under 18 years of age, fewer deaths were due to SIDS in the vaccinated, 
thanin the general population (13% versus 16% respectively). (McCarthy, et al., 2013)
In conclusion, vaccines are recommended by the CDC, the American Academy of 
Pediatrics, the American Academy of Family Physicians, and many other organizations 
because they save lives and the health benefits far outweigh any risks. When vaccination 
coverage rates decrease, the potential for life-threatening vaccine-preventable diseases to 
return increases. Nurses have a key role in helping to maintain high vaccination coverage by 
communicating with patients and parents about the benefits of vaccination and vaccine 
safety. Providing accurate and timely information on vaccine safety can help address nurses’ 
and other health care professionals’ concerns and might help to allay fears of vaccine 
hesitant parents and patients.
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Table 1
CDC Inquiry Portals
Resource Description Email address, telephone number, or
website
Purpose
CDC-INFO CDC’s national contact 
center
http://wwwn.cdc.gov/dcs/RequestForm.aspx, 1-800-CDC-INFO Answer health and public 
health questions
NIPINFO CDC’s immunization and 
vaccine-preventable 
disease email inquiry 
system
NIPINFO@cdc.gov Answer questions on 
vaccination
CDC EOC CDC’s Emergency 
Operations Center
770-488-7100 Respond to public health 
emergencies
VAERS1 Vaccine Adverse Event 
Reporting System
Info@vaers.org, 1-800-822-7967 Answer questions on 
VAERS reporting
CISA2 Clinical Immunization 
Safety Assessment Project
CISAeval@cdc.gov Provide consultation to 
health care professionals on 
patients with complex 
vaccine safety issues
1.
CDC administers and manages the VAERS program through a contractor that provides help desk services.
2.
CISA requests that do not meet the requirements for a clinical review are referred to the CDC Immunization Safety Office inquiry response 
program.
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TABLE 2
Additional Resources for Nurses
In addition to the CDC inquiry portals, there are several publicly available sources of vaccine safety information.
• Food and Drug Administration (FDA) vaccine package inserts: www.fda.gov/BiologicsBloodVaccines/Vaccines/
ApprovedProducts/UCM093833
• CDC Immunization information for health care professionals: www.cdc.gov/vaccines/hcp.htm
• CDC Vaccine Safety information: www.cdc.gov/vaccinesafety/index.htm
• CDC Immunization education and training for health professionals: www.cdc.gov/vaccines/ed/default.htm
• CDC Immunization training and information on Twitter: https://twitter.com/cdcizlearn/
• CDC Vaccine Information Statements: www.cdc.gov/vaccines/hcp/vis/index.html
• ACIP Vaccine Recommendations and Guidelines: www.cdc.gov/vaccines/hcp/acip-recs/index.html
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